{"id":3041,"date":"2008-12-09T11:39:11","date_gmt":"2008-12-09T15:39:11","guid":{"rendered":"http:\/\/chimeraobscura.com\/vm\/?p=3041"},"modified":"2008-12-09T11:39:11","modified_gmt":"2008-12-09T15:39:11","slug":"my-biggest-fault-well-im-a-bit-of-a-perfectionist","status":"publish","type":"post","link":"http:\/\/chimeraobscura.com\/vm\/my-biggest-fault-well-im-a-bit-of-a-perfectionist","title":{"rendered":"My biggest fault? Well, I’m a bit of a perfectionist. . ."},"content":{"rendered":"

Merck gave a “state of the biz-nass” presentation today. Here’s their statement<\/a> about it. As with every other major pharma company, they plan to<\/p>\n

    \n
  1. develop more vaccines and biologic drugs<\/li>\n
  2. sell more in emerging markets like India and China<\/li>\n
  3. use “diversity” when they mean “diversification”<\/li>\n<\/ol>\n

    My favorite statement was this sentence on the company’s “focus”:<\/p>\n

    The Company is focused on developing novel, best-in-class or follow-on treatments for patients in primary care, specialty care, and hospital settings.<\/p><\/blockquote>\n

    That is, they’re “focused” on making all types of drugs for all settings.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Merck gave a “state of the biz-nass” presentation today. Here’s their statement about it. As with every other major pharma company, they plan to develop more vaccines and biologic drugs sell more in emerging markets like India and China use “diversity” when they mean “diversification” My favorite statement was this sentence on the company’s “focus”: … <\/p>\n

    Continue reading “My biggest fault? Well, I’m a bit of a perfectionist. . .”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[27,12],"tags":[484],"class_list":["post-3041","post","type-post","status-publish","format-standard","hentry","category-big-business","category-pharmaceuticals","tag-merck"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p4C7K-N3","jetpack_likes_enabled":true,"jetpack-related-posts":[{"id":613,"url":"http:\/\/chimeraobscura.com\/vm\/613","url_meta":{"origin":3041,"position":0},"title":"Wah, Wah, Wah,","author":"Gil","date":"August 31, 2005","format":false,"excerpt":"[Here's the From the Editor page for the latest issue of my magazine]By now, the story of the first Vioxx lawsuit is old news. Merck was found liable in the death of Robert Ernst and the Texas jury awarded more than $250 million to his widow. State laws will knock\u2026","rel":"","context":"In "Pharmaceuticals"","block_context":{"text":"Pharmaceuticals","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business\/pharmaceuticals"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1161,"url":"http:\/\/chimeraobscura.com\/vm\/let-them-eat-tort","url_meta":{"origin":3041,"position":1},"title":"Let Them Eat Tort","author":"Gil","date":"October 15, 2006","format":false,"excerpt":"(here's the From the Editor column from my magazine this month) Sometimes, writing this column requires compulsive news-trawling, and my paranoid-detective method of reading people's quotes. It can be a painstaking process, involving market and biographical research, trend analysis, and interpretations of government health statistics. And sometimes there's a Vioxx\u2026","rel":"","context":"In "Big Business"","block_context":{"text":"Big Business","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":623,"url":"http:\/\/chimeraobscura.com\/vm\/what-goes-on-3","url_meta":{"origin":3041,"position":2},"title":"What Goes On","author":"Gil","date":"August 22, 2005","format":false,"excerpt":"Hey, gentlereader! Sorry to be absent for a while (except for those little goofy posts). I've been in a little bit of a writing-malaise lately, taking a mini-summer break.I've also been exercising for the first time in forever. The upside is that I'm feeling a bazillion times better, even though\u2026","rel":"","context":"In "literature"","block_context":{"text":"literature","link":"http:\/\/chimeraobscura.com\/vm\/category\/literature"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":1540,"url":"http:\/\/chimeraobscura.com\/vm\/the-perfect-alibi","url_meta":{"origin":3041,"position":3},"title":"The perfect alibi","author":"Gil","date":"June 6, 2007","format":false,"excerpt":"Phil Spector couldn't possibly have killed Lana Clarkson! He was busy conducting drug-assays for Merck KgA!","rel":"","context":"In "Pharmaceuticals"","block_context":{"text":"Pharmaceuticals","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business\/pharmaceuticals"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":3681,"url":"http:\/\/chimeraobscura.com\/vm\/english-do-you-speak-it","url_meta":{"origin":3041,"position":4},"title":"ENGLISH! DO YOU SPEAK IT?","author":"Gil","date":"March 26, 2009","format":false,"excerpt":"I had to read several paragraphs into this press release -- -- before I realized that Merck KGaA's bio-unit was not actually planning to exit San Diego.","rel":"","context":"In "Big Business"","block_context":{"text":"Big Business","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":252,"url":"http:\/\/chimeraobscura.com\/vm\/hiatus","url_meta":{"origin":3041,"position":5},"title":"Hiatus","author":"Gil","date":"June 26, 2004","format":false,"excerpt":"No blogging for me. I'm sick as a dog (summer colds suck), and have to put together the annual Top Companies report (top 20 pharma, top 10 biopharma) for my magazine.Now if you'll excuse me, I have to explain why last year's optimism about Merck was misguided . . .","rel":"","context":"In "Pharmaceuticals"","block_context":{"text":"Pharmaceuticals","link":"http:\/\/chimeraobscura.com\/vm\/category\/big-business\/pharmaceuticals"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/posts\/3041","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/comments?post=3041"}],"version-history":[{"count":1,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/posts\/3041\/revisions"}],"predecessor-version":[{"id":3042,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/posts\/3041\/revisions\/3042"}],"wp:attachment":[{"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/media?parent=3041"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/categories?post=3041"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/chimeraobscura.com\/vm\/wp-json\/wp\/v2\/tags?post=3041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}